151 related articles for article (PubMed ID: 21461979)
1. TWIST1 promoter methylation in primary colorectal carcinoma.
Ruppenthal RD; Nicolini C; Filho AF; Meurer R; Damin AP; Rohe A; Alexandre CO; Damin DC
Pathol Oncol Res; 2011 Dec; 17(4):867-72. PubMed ID: 21461979
[TBL] [Abstract][Full Text] [Related]
2. TWIST1 hypermethylation is observed frequently in colorectal tumors and its overexpression is associated with unfavorable outcomes in patients with colorectal cancer.
Okada T; Suehiro Y; Ueno K; Mitomori S; Kaneko S; Nishioka M; Okayama N; Sakai K; Higaki S; Hazama S; Hirata H; Sakaida I; Oka M; Hinoda Y
Genes Chromosomes Cancer; 2010 May; 49(5):452-62. PubMed ID: 20140954
[TBL] [Abstract][Full Text] [Related]
3. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
[TBL] [Abstract][Full Text] [Related]
4. TWIST1 promoter methylation is associated with prognosis in tonsillar squamous cell carcinoma.
Kwon MJ; Kwon JH; Nam ES; Shin HS; Lee DJ; Kim JH; Rho YS; Sung CO; Lee WJ; Cho SJ
Hum Pathol; 2013 Sep; 44(9):1722-9. PubMed ID: 23664538
[TBL] [Abstract][Full Text] [Related]
5. TWIST1 is expressed in colorectal carcinomas and predicts patient survival.
Gomez I; Peña C; Herrera M; Muñoz C; Larriba MJ; Garcia V; Dominguez G; Silva J; Rodriguez R; Garcia de Herreros A; Bonilla F; Garcia JM
PLoS One; 2011 Mar; 6(3):e18023. PubMed ID: 21464926
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of TWIST1 and EZH2 Expression in Colon Cancer.
Abdel Raouf SM; Ibrahim TR; Abdelaziz LA; Farid MI; Mohamed SY
J Gastrointest Cancer; 2021 Mar; 52(1):90-98. PubMed ID: 31823218
[TBL] [Abstract][Full Text] [Related]
7. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
8. TWIST1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer.
Valdés-Mora F; Gómez del Pulgar T; Bandrés E; Cejas P; Ramírez de Molina A; Pérez-Palacios R; Gallego-Ortega D; García-Cabezas MA; Casado E; Larrauri J; Nistal M; González-Barón M; García-Foncillas J; Lacal JC
Ann Surg Oncol; 2009 Jan; 16(1):78-87. PubMed ID: 19002529
[TBL] [Abstract][Full Text] [Related]
9. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of the MLH1 promoter with concomitant absence of transcript and protein occurs in small patches of crypt cells in unaffected mucosa from sporadic colorectal carcinoma.
Nuovo GJ; Nakagawa H; Sotamaa K; Chapelle Ade L
Diagn Mol Pathol; 2006 Mar; 15(1):17-23. PubMed ID: 16531764
[TBL] [Abstract][Full Text] [Related]
11. Identification of targets of Twist1 transcription factor in thyroid cancer cells.
Di Maro G; Orlandella FM; Bencivenga TC; Salerno P; Ugolini C; Basolo F; Maestro R; Salvatore G
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1617-26. PubMed ID: 24848707
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix.
Missaoui N; Hmissa S; Trabelsi A; Traoré C; Mokni M; Dante R; Frappart L
Pathol Res Pract; 2011 Jan; 207(1):37-42. PubMed ID: 21129853
[TBL] [Abstract][Full Text] [Related]
13. Twist1 is up-regulated in gastric cancer-associated fibroblasts with poor clinical outcomes.
Sung CO; Lee KW; Han S; Kim SH
Am J Pathol; 2011 Oct; 179(4):1827-38. PubMed ID: 21854747
[TBL] [Abstract][Full Text] [Related]
14. TWIST1 upregulates the MAGEA4 oncogene.
Forghanifard MM; Rad A; Farshchian M; Khaleghizadeh M; Gholamin M; Moghbeli M; Abbaszadegan MR
Mol Carcinog; 2017 Mar; 56(3):877-885. PubMed ID: 27533647
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of DNA methylation in promoter regions of hTERT, TWIST1, VIM and NID2 genes in Moroccan bladder cancer patients.
El Azzouzi M; El Ahanidi H; Hafidi Alaoui C; Chaoui I; Benbacer L; Tetou M; Hassan I; Bensaid M; Oukabli M; Ameur A; Al Bouzidi A; El Mzibri M; Attaleb M
Cancer Genet; 2022 Jan; 260-261():41-45. PubMed ID: 34922269
[TBL] [Abstract][Full Text] [Related]
16. Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.
Yang H; Hu H; Gou Y; Hu Y; Li H; Zhao H; Wang B; Li P; Zhang Z
Int J Clin Oncol; 2018 Apr; 23(2):321-328. PubMed ID: 29101499
[TBL] [Abstract][Full Text] [Related]
17. Twist1 causes the transcriptional repression of claudin-4 with prognostic significance in esophageal cancer.
Lee KW; Lee NK; Kim JH; Kang MS; Yoo HY; Kim HH; Um SH; Kim SH
Biochem Biophys Res Commun; 2012 Jul; 423(3):454-60. PubMed ID: 22668877
[TBL] [Abstract][Full Text] [Related]
18. Highly sensitive faecal DNA testing of TWIST1 methylation in combination with faecal immunochemical test for haemoglobin is a promising marker for detection of colorectal neoplasia.
Suehiro Y; Zhang Y; Hashimoto S; Takami T; Higaki S; Shindo Y; Suzuki N; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
Ann Clin Biochem; 2018 Jan; 55(1):59-68. PubMed ID: 28081635
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer.
Gort EH; Suijkerbuijk KP; Roothaan SM; Raman V; Vooijs M; van der Wall E; van Diest PJ
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3325-30. PubMed ID: 19064546
[TBL] [Abstract][Full Text] [Related]
20. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition.
Nam EH; Lee Y; Moon B; Lee JW; Kim S
Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
